Sonoma Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2011 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.34M shares, a 74.2% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.34M -3.84M -74.2% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 19M +13.9M +270% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 780K -4.15M -84.2% Mar 31, 2024 10-Q 2024-11-07
Q4 2023 13.7M +10.6M +340% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 5.18M +2.08M +66.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 5.14M +2.04M +65.8% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 4.93M +1.83M +59.1% Mar 31, 2023 10-K 2024-06-17
Q4 2022 3.11M +1.02M +48.6% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 3.1M +98.2K +3.27% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 3.1M +1.01M +48.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 3.1M +1.01M +48.2% Mar 31, 2022 10-K 2023-06-21
Q4 2021 2.09M +13.9K +0.67% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 3M +963K +47.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 2.09M +126K +6.4% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 2.09M +315K +17.7% Mar 31, 2021 10-K 2022-07-13
Q4 2020 2.08M +302K +17% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 2.04M +723K +54.9% Sep 30, 2020 10-Q 2020-11-20
Q2 2020 1.97M +650K +49.3% Jun 30, 2020 10-Q/A 2020-11-17
Q1 2020 1.78M +461K +35% Mar 31, 2020 10-K 2021-07-14
Q4 2019 1.78M -10.2M -85.2% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 1.32M -5.16M -79.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 1.32M -5.12M -79.5% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 1.32M +631K +92% Mar 31, 2019 10-K 2020-07-10
Q4 2018 12M +7.33M +158% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 6.48M +2.16M +49.9% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 6.43M +2.13M +49.4% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 686K -3.6M -84% Mar 31, 2018 10-K 2019-07-01
Q4 2017 4.64M +380K +8.92% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 4.32M +118K +2.8% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 4.31M +106K +2.53% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 4.29M +92.4K +2.2% Mar 31, 2017 10-K 2018-06-26
Q4 2016 4.26M -13.1M -75.4% Dec 31, 2016 10-Q 2017-02-17
Q3 2016 4.21M -12.2M -74.4% Sep 30, 2016 10-Q 2016-11-15
Q2 2016 4.2M -11.5M -73.2% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 4.2M -10.8M -72.1% Mar 31, 2016 10-K 2017-06-28
Q4 2015 17.3M +8.68M +100% Dec 31, 2015 10-Q 2016-02-16
Q3 2015 16.4M +7.83M +91.2% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 15.7M +7.22M +85.4% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 15M +6.88M +84.4% Mar 31, 2015 10-K 2016-06-21
Q4 2014 8.66M +1.42M +19.6% Dec 31, 2014 10-Q 2015-02-12
Q3 2014 8.59M +1.95M +29.4% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 8.46M +1.83M +27.7% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 8.16M +1.58M +24% Mar 31, 2014 10-K 2015-06-16
Q4 2013 7.24M -30.1M -80.6% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 6.63M -26.1M -79.8% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 6.63M -25.9M -79.6% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 6.58M +2.44M +58.9% Mar 31, 2013 10-K 2014-06-30
Q4 2012 37.3M +8.48M +29.4% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 32.8M +5.91M +22% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 32.6M +5.8M +21.7% Jun 30, 2012 10-Q/A 2012-08-31
Q1 2012 4.14M -22.4M -84.4% Mar 31, 2012 10-K 2013-06-25
Q4 2011 28.9M Dec 31, 2011 10-Q 2012-02-10
Q3 2011 26.9M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 26.8M Jun 30, 2011 10-Q/A 2011-08-09
Q1 2011 26.6M Mar 31, 2011 10-K 2012-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.